Guidelines for Clinical Research on Acupuncture
(1995; 68 pages)
Table of Contents
View the documentForeword
Open this folder and view contents1. Introduction
Open this folder and view contents2. Glossary
Open this folder and view contents3. Goals and objectives of the guidelines
Open this folder and view contents4. General considerations
Close this folder5. Research methodology
View the documentLiterature review
View the documentTerminology and technology
View the documentInvestigators
View the documentClinical research design and rational use of acupuncture
View the documentRandomized controlled clinical trial design
View the documentProtocol development
View the documentResearch knowledge
View the documentCase report forms
View the documentData management
View the documentEthics review board
View the documentStatistical analysis
View the documentMonitoring of studies
View the documentReporting
View the documentImplementation
View the documentConclusions
View the document6. Using the guidelines
Open this folder and view contentsAnnexes
View the documentBibliography
View the documentSelected WHO publications of related interest
View the documentBack cover

Data management

The aim of record-keeping and handling of data is to gather information from the study without error in a form that can later be analysed and reported. The investigator and monitor must ensure that the data are of the highest possible quality at the point of collection. A case report form (CRF) for each patient in the study must be completed and signed by the investigator and assessor. The CRF is designed to record data on each trial subject during the course of the trial, as defined by the protocol. The data should be collected by procedures which guarantee preservation, retention and retrieval of information, and allow easy access for verification and audit. The patient’s files, CRFs and other sources of primary data must be kept for future reference. Patient data must be handled in a way that maintains confidentiality and yet ensures accuracy. The condition of the patient before treatment, and the response to the treatment, including the observations of the assessor, the feelings of the patient and possible adverse effects, need to be fully documented. All efforts should be made to maintain error-free records.

When subjects are randomized to different groups, the randomization procedure used must be documented.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017